Adjuvant atezolizumab in Japanese patients with resected stage <scp>IB‐IIIA</scp> non‐small cell lung cancer (<scp>IMpower010</scp>)Hirotsugu Kenmotsu, Haruka Nagao, Morihito Okada et al.|Cancer Science|2022Cited by 20
Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE)Akito Hata, Tomohide Tamura, Yoshimasa Shiraishi et al.|Oncology and Therapy|2022Cited by 17